Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation

키워드

참고문헌 (22)

1. Rodan GA, "Therapeutic approaches to bone diseases", Science, 289, pp.1508~1514 (2000)
2. Teitelbaum SL, "Genetic regulation of osteoclast development and function", Nat Rev Genet, 4, pp.638~649 (2003)
3. Suda T, "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families", Endocr Rev, 20, pp.345~357 (1999)
4. Hofbauer LC, "The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption", J Bone Miner Res, 15, pp.2~12 (2000)
5. Mócsai A, "The immunomodulatory adapter proteins DAP12 and Fc receptor gammachain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase", Proc Natl Acad Sci U S A, 101, pp.6158~6163 (2004)
6. Koga T, "Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis", Nature, 428, pp.758~763 (2004)
7. Takayanagi H, "Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7, pp.292~304 (2007)
8. Matsuo K, "Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos", J Biol Chem, 279, pp.26475~26480 (2004)
9. 김광미, "RANKL에 의해 유도되는 뼈파괴세포(Osteoclast) 분화에 미치는 모과의 효과", Anatomy and Cell Biology, 42(3), pp.179~185 (2009), 대한해부학회
10. 곽한복, "녹용 물 추출물의 파골세포 분화 억제효과", 동의생리병리학회지, 22(4), pp.891~895 (2008), 대한동의병리학회
11. 곽성철, "골쇄보가 RANKL에 의해 유도되는 파골세포의 분화에 미치는 영향", 동의생리병리학회지, 26(4), pp.506~510 (2012), 대한동의병리학회[DOI]
12. Kang DG, "Cornuside suppresses cytokine-induced proinflammatory and adhesion molecules in the human umbilical vein endothelial cells", Biol Pharm Bull, 30, pp.1796~1799 (2007)
13. Choi YH, "Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages", Biol Pharm Bull, 34, pp.959~966 (2011)
14. Telang NT, "Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor-positive clinical breast cancer", Mol Med Report, 5, pp.22~28 (2012)
15. 곽한복, "Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression", BONE, 46, pp.724~731 (2010), ELSEVIER SCIENCE INC
16. Boonen S, "Fracture risk and zoledronic acid therapy in men with osteoporosis", N Engl J Med, 367, pp.1714~1723 (2012)
17. Mohamed SG, "Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells", Bone, 41, pp.592~602 (2007)
18. Huang H, "Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway", Biochem Biophys Res Commun, 351, pp.99~105 (2006)
19. Srivastava S, "Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation", J Biol Chem, 276, pp.8836~8840 (2001)
20. Yamashita T, "NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1", J Biol Chem, 282, pp.18245~18253 (2007)
21. Jeong-Tae Yeon, "Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway", BMB Reports, 45(3), pp.171~176 (2012), 생화학분자생물학회
22. Magnani M, "The ubiquitindependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB)", Curr Drug Targets, 1, pp.387~399 (2000)

관련 논문AI추천